Professionnels de santé

Grand public

Transparency Committee Opinion

Date	04 November 2009
Pharmaceutical formulation	RANEXA 375 mg extended release tablet Pack of 60 (CIP: 394 370-7) RANEXA 500 mg extended release tablet Pack of 60 (CIP: 394 373-6) RANEXA 750 mg extended release tablet Pack of 60 (CIP: 394 375-9)
ATC code	C01EB18
Active ingredient	ranolazine
Laboratory / Manufacturer	A. MENARINI FARMACEUTICA INTERNAZIONALE SRL
Reason for request	Inclusion on the list of medicines reimbursed by National Health Insurance and approved for use by hospitals.